It is well known that tumor necrosis factor-α (TNF-α) activates MAPKs and NF-κB, which interfere with peroxisome proliferator-activated receptor gamma (PPAR-γ) activity, decreasing insulin signaling and trigger inflammatory reactions, ultimately resulting in insulin resistance and adipose dysfunction [274]. Here, NFKB1 is linked to Insulin resistance.